Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:43:09.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study results related to a Phase II Randomized Controlled Screening Trial of Nivolumab for the treatment of Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
    Difference
    0.1%
    Check dated 2024-06-06T14:42:19.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as signed informed consent, health conditions, and prior treatments. This change provides more comprehensive information for researchers and potential participants about who can join the study.
    Difference
    53%
    Check dated 2024-05-22T21:23:56.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:33:01.000Z thumbnail image

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.